1. Home
  2. GAB vs HRMY Comparison

GAB vs HRMY Comparison

Compare GAB & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GAB
  • HRMY
  • Stock Information
  • Founded
  • GAB 1986
  • HRMY 2017
  • Country
  • GAB United States
  • HRMY United States
  • Employees
  • GAB N/A
  • HRMY N/A
  • Industry
  • GAB Investment Managers
  • HRMY Biotechnology: Pharmaceutical Preparations
  • Sector
  • GAB Finance
  • HRMY Health Care
  • Exchange
  • GAB Nasdaq
  • HRMY Nasdaq
  • Market Cap
  • GAB 1.6B
  • HRMY 1.9B
  • IPO Year
  • GAB N/A
  • HRMY 2020
  • Fundamental
  • Price
  • GAB $5.70
  • HRMY $34.07
  • Analyst Decision
  • GAB
  • HRMY Buy
  • Analyst Count
  • GAB 0
  • HRMY 9
  • Target Price
  • GAB N/A
  • HRMY $47.00
  • AVG Volume (30 Days)
  • GAB 667.8K
  • HRMY 1.2M
  • Earning Date
  • GAB 01-01-0001
  • HRMY 10-29-2024
  • Dividend Yield
  • GAB 10.91%
  • HRMY N/A
  • EPS Growth
  • GAB N/A
  • HRMY N/A
  • EPS
  • GAB N/A
  • HRMY 2.11
  • Revenue
  • GAB N/A
  • HRMY $681,879,000.00
  • Revenue This Year
  • GAB N/A
  • HRMY $24.79
  • Revenue Next Year
  • GAB N/A
  • HRMY $17.98
  • P/E Ratio
  • GAB N/A
  • HRMY $16.18
  • Revenue Growth
  • GAB N/A
  • HRMY 25.83
  • 52 Week Low
  • GAB $4.56
  • HRMY $28.14
  • 52 Week High
  • GAB $5.88
  • HRMY $41.61
  • Technical
  • Relative Strength Index (RSI)
  • GAB 68.33
  • HRMY 49.07
  • Support Level
  • GAB $5.33
  • HRMY $32.33
  • Resistance Level
  • GAB $5.57
  • HRMY $33.66
  • Average True Range (ATR)
  • GAB 0.06
  • HRMY 1.17
  • MACD
  • GAB 0.01
  • HRMY -0.03
  • Stochastic Oscillator
  • GAB 100.00
  • HRMY 40.00

About GAB Gabelli Equity Trust Inc. (The)

Gabelli Equity Trust Inc is a non-diversified closed-end management investment company. Its primary investment objective is the long-term growth of capital with income as a secondary objective. The Fund invests at least its assets in equity securities under normal market conditions. Its equity portfolio includes common stock, preferred stock, convertible or exchangeable securities, and warrants and rights to purchase such securities selected by the Investment Adviser. The company invests in various sectors, of which Food & Beverage, Financial Services, Equipment and Supplies, Entertainment, Consumer Products, Health Care, Diversified Industrial, Business Services, Consumer Services and others.

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant), is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy.

Share on Social Networks: